J. Goldman & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

J. Goldman & Co’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50,000	Closed	-$4.45M	–	468
2017 Q1	$4.45M	Buy	+50,000	New	+$4.11M	0.22%	136
2013 Q4	–	Sell	-50,000	Closed	-$3.71M	–	329
2013 Q3	$3.71M	Buy	+50,000	New	+$3.75M	0.35%	102

Other funds holding MJN

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FNBOO

First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

J. Goldman & Co's MJN Position: Q4 2013 in Review

J. Goldman & Co sold out of Mead Johnson Nutrition Company (MJN) in Q4 2013, closing a stake of 77,500 shares — an estimated $5.75M sold.

J. Goldman & Co first reported a position in MJN in Q3 2013 and held it in 1 quarter. The position peaked at $5.75M in Q3 2013. 483 funds tracked by Wall St. Rank hold MJN as of Q4 2013.

J. Goldman & Co reported no remaining Mead Johnson Nutrition Company position as of Q4 2013 after selling out during the quarter.
J. Goldman & Co sold 77,500 Mead Johnson Nutrition Company shares in Q4 2013, an estimated $5.75M.
J. Goldman & Co first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 1 quarter.
J. Goldman & Co's Mead Johnson Nutrition Company position peaked at $5.75M in Q3 2013.
483 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2013.

Based on J. Goldman & Co's 13F filing for Q4 2013, filed 14 Feb 2014.